Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema

Lung

Volumn 191, Issue 6, 2013, Pages 585-591

  Ando, Katsutoshi ^a   Sekiya, Mitsuaki ^a   Tobino, Kazunori ^b   Takahashi, Kazuhisa ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b ASO IIZUKA HOSPITAL   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Combined pulmonary fibrosis and emphysema; Computed tomography; Pulmonary function; Small pulmonary vessels

Indexed keywords

CARBON MONOXIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG BLOOD VESSEL; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION; LUNG GAS EXCHANGE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY AIRFLOW; SPIROMETRY; VITAL CAPACITY;

AGED; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 84890364601     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9513-1     Document Type: Article

References (26)

1. Cottin V, Nunes H, Brillet PY et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26:586-593
2. Mejía M, Carrillo G, Rojas-Serrano J et al (2009) Idiopathic pulmonary fibrosis and emphysema decreased survival associated with severe pulmonary arterial hypertension. Chest 136:10-15
3. Kitaguchi Y, Fujimoto K, Hanaoka M et al (2010) Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 15:265-271
4. Kurashima K, Takayanagi N, Tsuchiya N et al (2010) The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 15:843-848
5. Chiba S, Ohta H, Abe K et al (2012) The diagnostic value of the interstitial biomarkers KL-6 and SP-D for the degree of fibrosis in combined pulmonary fibrosis and emphysema. Pulm Med 492960
6. Austin JH, Muller NL, Colman N et al (1999) Diagnosis of disease of the chest. WB Saunders, Philadelphia, pp 2168-2263
7. Thurlbeck WM, Muller NL (1994) Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol 163:1017-1025
8. Sakai N, Mishima M, Nishimura K, Itoh H, Kuno K (1994) An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients. Chest 106:1319-1325
9. Mishima M, Hirai T, Itoh H et al (1999) Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 96:8829-8834
10. Nakano Y, Sakai H, Muro S et al (1999) Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 54:384-389
11. Matsuoka S, Washko GR, Yamashiro T et al (2010) Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 181:218-225
12. Matsuoka S, Washko GR, Dransfield MT et al (2010) Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol 17:93-99
13. Uejima I, Matsuoka S, Yamashiro T, Yagihashi K, Kurihara Y, Nakajima Y (2011) Quantitative computed tomographic measurement of a cross-sectional area of a small pulmonary vessel in nonsmokers without airflow limitation. Jpn J Radiol 29:251-255
14. Ando K, Tobino K, Kurihara M et al (2012) Quantitative CT analysis of small pulmonary vessels in lymphangioleiomyomatosis. Eur J Radiol 81:3925-3930
15. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2011) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung and Blood Institute, World Health Organization, Bethesda
16. Sharp DS (1993) Reference values for lung function in the Japanese: recording of normal lung function from 11 institutes in Japan. Jpn J Thoracic Dis 31:421-427
17. Demedts M, Behr J, Buhl R et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229-2242
18. Taniguch H, Ebina M, Kondoh Y et al (2010) Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35:821-829
19. Richeldi L, Costabel U, Selman M et al (2011) Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365:1079-1087
20. Santos S, Peinado VI, Ramirez J et al (2003) Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1250-1256
21. Barr RG, Mesia-Vela S, Austin JH et al (2007) Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the emphysema and cancer action project (EMCAP) Study. Am J Respir Crit Care Med 176:1200-1207
22. Farkas L, Gauldie J, Voelkel NF et al (2011) Pulmonary hypertension and idiopathic pulmonary fibrosis. Am J Cell Mol Biol 45:1-15
23. Judge EP, Fabre A, Adamali HI et al (2012) Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J 40:93-100
24. Ebina M, Shimizukawa M, Shibata et al (2004) Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 169:1203-1208
25. Simler NR, Brenchley PE, Horrocks AW et al (2004) Angiogenic cytokines in patients in patients with idiopathic pulmonary fibrosis. Thorax 59:581-585
26. Cosgrove GP, Brown KK, Schiemann WP et al (2004) Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 170:242-251